Esperion Therapeutics Inc (NASDAQ:ESPR)

1.34
BATS BZX Real-Time Price
As of 3:52pm ET
 +0.065 / +5.12%
Today’s Change
0.70
Today|||52-Week Range
8.87
-78.57%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Esperion Therapeutics Inc have a median target of 7.00, with a high estimate of 22.00 and a low estimate of 2.00. The median estimate represents a +424.34% increase from the last price of 1.34.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Esperion Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.42
Sales
$34.7M
Reporting Date
Feb 20

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -13.49%
 
 
 
 
 
 
Growthannually 36.28%
 
 
 
 
 
 

Sales

Growthquarterly 2.19%
 
 
 
 
 
 
Growthannually 50.40%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.